Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$20.09 - $35.8 $576,803 - $1.03 Million
28,711 New
28,711 $603,000
Q4 2021

Feb 11, 2022

SELL
$33.11 - $55.01 $3,410 - $5,666
-103 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$50.07 - $66.05 $139,945 - $184,609
-2,795 Reduced 96.45%
103 $5,000
Q2 2021

Aug 09, 2021

SELL
$56.61 - $80.46 $199,153 - $283,058
-3,518 Reduced 54.83%
2,898 $182,000
Q1 2021

May 14, 2021

SELL
$86.23 - $125.19 $609,387 - $884,717
-7,067 Reduced 52.41%
6,416 $596,000
Q4 2020

Feb 11, 2021

SELL
$79.17 - $111.47 $119,150 - $167,762
-1,505 Reduced 10.04%
13,483 $1.21 Million
Q3 2020

Nov 12, 2020

BUY
$81.91 - $134.94 $484,251 - $797,765
5,912 Added 65.14%
14,988 $1.55 Million
Q2 2020

Aug 13, 2020

BUY
$54.33 - $89.52 $409,213 - $674,264
7,532 Added 487.82%
9,076 $719,000
Q1 2020

May 13, 2020

BUY
$49.34 - $68.76 $69,766 - $97,226
1,414 Added 1087.69%
1,544 $90,000
Q4 2019

Feb 12, 2020

SELL
$51.21 - $59.06 $226,143 - $260,808
-4,416 Reduced 97.14%
130 $7,000
Q3 2019

Nov 14, 2019

SELL
$40.6 - $57.2 $65,934 - $92,892
-1,624 Reduced 26.32%
4,546 $238,000
Q2 2019

Aug 07, 2019

SELL
$39.92 - $53.86 $112,135 - $151,292
-2,809 Reduced 31.28%
6,170 $297,000
Q1 2019

May 10, 2019

SELL
$48.23 - $66.16 $483,264 - $662,923
-10,020 Reduced 52.74%
8,979 $0
Q2 2018

Aug 10, 2018

BUY
$48.33 - $55.64 $3,141 - $3,616
65 Added 0.34%
18,999 $953,000
Q1 2018

May 08, 2018

BUY
$44.44 - $54.39 $642,469 - $786,316
14,457 Added 322.92%
18,934 $997,000
Q4 2017

Feb 13, 2018

BUY
$37.77 - $47.75 $169,096 - $213,776
4,477
4,477 $208,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.